U.S. clinical trial begins for Endosense's ablation catheter

02/5/2013 | AuntMinnie.com (free registration)

The University of Virginia Medical Center in Charlottesville has become the first in the U.S. to use Endosense's TactiCath Quartz ablation catheter as part of an investigational device exemption clinical trial of the device. Trial results will be used to back the company's FDA premarket approval application for the system, which it aims to file during the fourth quarter of this year.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY